Home › Funds › Trails Edge Capital Partners, LP › KLRA

Trails Edge Capital Partners, LP position in KLRA

KAILERA THERAPEUTICS INC · Health Care

Trails Edge Capital Partners, LP reported holding 942,953 shares of KLRA (KAILERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 1.55% of its reported portfolio and ranking #24 among its reported holdings. Trails Edge Capital Partners, LP has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)942.95K sh
Reported value held$10.77M
Portfolio Weight1.55%
First reportedQ2 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's KLRA position evolved

Trails Edge Capital Partners, LP first disclosed a stake in KLRA in Q2 2026 at 984,786 shares (US$21.7M). Across 2 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 942,953 shares valued at US$10.8M — a reduction of -41,833 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 984.79K $21.69M New
Q3 2026 942.95K $10.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KLRA and 13F data

KLRA (KAILERA THERAPEUTICS INC) is a Health Care company. 134 other funds we track also report a position in KLRA — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$299.8M), Bain Capital Life Sciences Investors, LLC (US$257.9M), RTW INVESTMENTS, LP (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KLRA

All KLRA fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held KLRA?

Trails Edge Capital Partners, LP has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Trails Edge Capital Partners, LP's current position in KLRA?

As of Q3 2026, Trails Edge Capital Partners, LP holds 942.95K shares of KLRA (KAILERA THERAPEUTICS INC), valued at $10.77M, representing 1.55% of its reported portfolio and ranking #24.

Has Trails Edge Capital Partners, LP been buying or selling KLRA?

In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP reduced its position in KLRA.

Which other funds hold KLRA?

Other major institutional holders of KLRA include BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, among 134 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.